International Clinical Trial: A multicenter real-world study on consolidation treatment with PD-L1/PD-1 immune checkpoint inhibitors in limited-stage small cell lung cancer after no progression with concurrent chemoradiotherapy

Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125754) titled 'A multicenter real-world study on consolidation treatment with PD-L1/PD-1 immune checkpoint inhibitors in limited-stage small cell lung cancer after no progression with concurrent chemoradiotherapy' on May 31.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Cancer Hospital Affiliated to Shandong First Medical University

Condition: small cell lung cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Case series :1000;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=32089...